Medicare set to expand coverage of PET (positron emission tomography) scans but only for a limited list of applications
This article was originally published in Clinica
The US Health Care Financing Administration (HCFA) has decided to expand Medicare coverage of positron emission tomography (PET) scans to include the diagnosis or management of certain types of cancer. However, the agency is proposing to cover fewer and far narrower indications than were recommended by patient advocates, trade groups and some clinicians at the HCFA-sponsored meeting in January.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.